Clinical Trials Browser

Phase 2 × Sarcoma × Vascular Endothelial Growth Factor A × Clear all

NCT00288015 2018-06-25

Bevacizumab in Treating Patients With Angiosarcoma

Phase 2 Completed

32 enrolled 12 charts

Hemangiosarcoma, Sarcoma